Please find enclosed herewith pdf of Change in Management for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 1.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Boston Bio Systems Limited held a board meeting on May 12, 2025 that resulted in a sweeping leadership change. Four members resigned with immediate effect — Managing Director Pratik Satish Patil, Additional Director Seema Baghel, Executive Director Sadhana Satish Patil, and CFO Manpreet Doad Powani — all citing 'pre-occupation and personal commitments.' To fill the gaps, the board appointed VishnuBhai Desai (a real estate businessman) as the new Managing Director, Kunjan Nathabhai Rathod (from the transport and logistics sector) as the new CFO, and Yash Arun Chaudhary as a Non-Executive Non-Independent Director. Additionally, Ghanshyam Gavali's designation was changed from Independent Director to Executive Director, and all board committees (Audit, Nomination & Remuneration, Stakeholders' Relationship) were reconstituted. Note: BSE scrip code 531458 belongs to Boston Bio Systems, not Boston Commerce Ltd as the headline suggests.
This is an unusually large shake-up for a small-cap company, with both the Managing Director and CFO stepping down on the same day and being replaced by professionals from unrelated industries (real estate and logistics). Retail investors should watch for clarity on strategic direction and whether the new leadership's outside background aligns with the company's bio-systems business.